KRAS and adenoma: BRAF or KRAS mutations were observed in both non-dysplastic or dysplastic sessile serrated adenomas; most MLH1-deficient sessile serrated adenomas with dysplasia displayed RNF43 mutations less frequent in sessile serrated adenomas with retained MLH1 expression [187].